Evergreen Nephrology - Funding Was Led by Rubicon Founders, Oak Hc/FT and Group of Existing Investors, With Addition of K2 Healthventures
常青腎臟病學 - 融資由Rubicon創始人、Oak Hc/Ft以及一組現有投資者主導,並加入了K2 Healthventures。
Evergreen Nephrology - Funding Was Led by Rubicon Founders, Oak Hc/FT and Group of Existing Investors, With Addition of K2 Healthventures
常青腎臟病學 - 融資由Rubicon創始人、Oak Hc/Ft以及一組現有投資者主導,並加入了K2 Healthventures。
使用瀏覽器的分享功能,分享給你的好友吧